@CSLBehring

We are driven by our promise to help patients lead full lives. See our community guidelines: https://xitter.cf/t.co/kApe7qvO6t

 King of Prussia, PA
cslbehring.com
Joined April 2009
  • Tweets4.1K
  • Following487
  • Followers9.3K
2.2KMedia
The “Makers on the Move” statewide bus tour is off to a great start with a visit to IMA member and 2023 Barry L. MacLean Manufacturer of the Year @CSL Behring to continue our celebration of @MfgDay and Manufacturing Month in Illinois! #MFGDay24 @IMECillinois #MakersOnTheMove
2
2
5
480
CSL Behring retweeted
CSL
@CSL20 Jun 2023
GROUNDBREAKING: First patient has received our FDA-approved gene therapy treatment in the United States. Check out our latest news here: bit.ly/46arAAX #CSL #DrivenByOurPromise
4
8
5
17
7,854
CSL Behring retweeted
CSL
@CSL14 Feb 2023
We’ve just released our Half Year Results for Financial Year 2023. See a snapshot of the results below. To download the announcement and register for the webcast visit our investor centre: bit.ly/40VEXCz
1
3
1
15
1,710
Head of #FDA CBER Peter Marks joins @drcwestphal and R&D heads from @CSLBehring and @Amgen in a #regulatory and industry roundtable. See full agenda: longwoodhealthcareleaders.co…
2
2
650
CSL Behring retweeted
CSL
@CSL13 Dec 2022
CSL announced Dr Paul McKenzie has been appointed CEO & Managing Director of CSL from 6 March 2023. Mr Paul Perreault, who has advised the Board of his intention to retire after serving 10 years in the role, and more than 25 years with the company. More: bit.ly/3HtfDfR
2
11
CSL Behring retweeted
CSL
@CSL12 Dec 2022
CSL announces Dr Paul McKenzie has been appointed CEO and Managing Director of CSL from 6 March 2023. Dr McKenzie, who is currently CSL’s Chief Operating Officer, will succeed Mr Paul Perreault, who has advised the Board of his intention to retire. More: bit.ly/3VPyYMs
1
1
18
CSL Behring retweeted
CSL
@CSL22 Nov 2022
Breaking: @US_FDA has approved our innovative new treatment for people living with hemophilia B. Learn more: cslbehring.com/newsroom
5
6
4
13
Great to meet the @CSLBehring team in Stockholm to learn more about how an iconic 🇦🇺 biotechnology company is helping save and improve lives across the Nordics.
1
7
CSL Behring retweeted
EUCOPE@EUCOPE13 Oct 2022
As a potentially one-off, transformative treatment, #ATMPs are different from many #therapies currently available or in development 🎙️Our latest #podcast discusses them and how they'll be impacted by the General Pharmaceutical Legislation 🎧spotifyanchor-web.app.link/e… @CSLBehring
1
3
CSL Behring retweeted
CSL
@CSL12 Oct 2022
🚧UNDER CONSTRUCTION🚧 - In November 2020, CSL Seqirus announced their new advanced-manufacturing biopharmaceutical facility, bringing cell- based technology to Melbourne, Australia. Check out the video to see how the build is progressing.
1
11
CSL Behring retweeted
CSL Plasma
@CSLPlasma3 Oct 2022
Today begins the 2022 International Plasma Awareness Week, designed to: - Raise global awareness about source plasma collection - Recognize contributions of donors to saving and improving lives & - Increase understanding about plasma protein therapies & rare diseases. #IPAW2022
2
5
2
16
CSL Behring retweeted
CSL
@CSL8 Sep 2022
✨THE LIGHTS ARE ON:✨ This week the CSL Melbourne project reached another milestone when the lights of our CSL logo at the top of the building were turned on. Members of the project gathered on Thursday evening to celebrate the illumination of the signs on our new headquarters.
1
4
23
This Friday join me, Professor @AL_Catapano and Professor Zeymer during #ESCCongress to talk about #CholesterolEfflux and its potential role in clinical outcomes for #HeartAttack survivors. Add to your calendar here: bit.ly/3crLiAT @CSLBehring – at Lambeth, London
2
7
1
21
CSL Behring retweeted
CSL
@CSL16 Aug 2022
CSL is pleased to announce our FY22 results. Watch the video below for a snapshot. For more: bit.ly/3QMZ6oj
1
3
11
CSL Behring retweeted
CSL
@CSL11 Aug 2022
With the addition of CSL Vifor*, we are blending two rich histories and adding a portfolio that includes nephrology and rare disease, kidney dialysis and iron therapy. #DrivenbyOurPromise bit.ly/3PiRTes
2
9
CSL Behring retweeted
CSL
@CSL10 Aug 2022
We recently welcomed CSL Vifor & broadened our scope to include the treatment of kidney disease, iron deficiency & more. We also unveiled a new look for the four CSL businesses: CSL Vifor, CSL Behring, CSL Plasma and CSL Seqirus. Learn more about #OneCSL bit.ly/3pbkmIG
4
10
CSL Behring retweeted
CSL Plasma
@CSLPlasma4 Aug 2022
We are celebrating the launch of the Rika Plasma Donation System at the Aurora, CO, CSL Plasma center. Only at CSL Plasma, Rika is designed to reduce collection time, & improve donor & operator experience. MORE: bit.ly/3JwHavQ #DotheAmazing
1
3
9
Join Anne-Sophie Lapointe, @yann_eurordis , @KnotekOndrej , Diane Kleinermans, @RIZIV_INAMI, Antti Kourula, @CSLBehring, @vivienneparry in a discussion on European Policy in Rare Disease! 🗓 : 16 June 2022 | 09:40-10:50 Register now 👇 live.europeanhealthsummit.eu
1
3
CSL Behring retweeted
PhRMA
@PhRMA18 May 2022
Disorders of the blood are varied and require different treatments. A sustained research and development pipeline of new medicines for these disorders is critical to improving and extending patient lives. Learn more about medicines in development: onphr.ma/3wBpsRJ
3
13
CSL Behring retweeted
CSL Behring
@CSLBehring28 Apr 2022
CSL Behring announced it is donating 500 million international units of coagulation factor replacement therapy to the @WFHemophilia Humanitarian Aid Program to help those living with bleeding disorders globally. bit.ly/3OIJSkc
1
6
1
30
Load more